Clozapine Tablet
Product Images NDC 65862-846

10 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 65862-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Clozapine Fig1)

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Clozapine Fig1)
A line graph showing the cumulative probability over time (months) of a significant suicide attempt or hospitalization to prevent suicide in patients with schizophrenia or schizoaffective disorder at high risk of suicidality. Two lines compare Clozapine and Olanzapine, with Clozapine showing a cumulative probability reaching about 24% and Olanzapine about 32% at 24 months.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Container))

Package Label-principal Display Panel (25 mg (100 Tablets Container))
Label for Clozapine Tablets USP 25 mg, showing a bottle label with the Aurobindo logo and branding. The label states each tablet contains Clozapine USP 25 mg, and the package size is 100 tablets. The label indicates the product is Rx only, provides storage instructions, and includes distributor information for Aurobindo Pharma USA, Inc., located in East Windsor, NJ. The label also includes a barcode and mentions the product is made in India.*
FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)

Package Label-principal Display Panel (25 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)
Packaging label for Clozapine Tablets USP 25 mg manufactured by Aurobindo Pharma Limited. The label indicates 100 unit-dose tablets (10 x 10) with a green 25 mg strength marker. It includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Container))

Package Label-principal Display Panel (50 mg (100 Tablets Container))
Label for Clozapine Tablets USP 50 mg, distributed by Aurobindo Pharma USA, Inc., made in India. The label shows dosage form as tablets with a count of 100, storage instructions, and a note for dosage information on the package insert. The label includes the NDC 65862-845-01 and mentions it is Rx only.*
FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)

Package Label-principal Display Panel (50 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)
Packaging label for Clozapine Tablets USP 50 mg, a prescription drug. The carton indicates a supply of 100 unit-dose tablets (10 x 10), distributed by Aurobindo Pharma USA, Inc. It includes storage instructions, dosage advisory, and notes on child resistance. The label shows the NDC number 65862-845-78 and identifies the product as made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Container))

Package Label-principal Display Panel (100 mg (100 Tablets Container))
Label for Clozapine Tablets USP 100 mg by Aurobindo Pharma Limited, with 100 tablets indicated. The label includes dosage form, strength, NDC 65862-846-01, storage instructions (20° to 25°C), and distributor information for Aurobindo Pharma USA, Inc. The label states Rx only and includes a barcode and a note about dispensing based on ANC results.*
FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)

Package Label-principal Display Panel (100 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)
Packaging label for Clozapine Tablets USP 100 mg by Aurobindo Pharma Limited. The label indicates the product contains 100 mg tablets in a 100-unit (10 x 10) unit-dose package, with the NDC 65862-846-78. It includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc., East Windsor, NJ.*
FDA Label Image

Package Label-principal Display Panel (200 mg (100 Tablets Container))

Package Label-principal Display Panel (200 mg (100 Tablets Container))
Label for Clozapine Tablets USP 200 mg from Aurobindo Pharma Limited, containing 100 tablets. The label includes dosage and storage instructions, distributor information for Aurobindo Pharma USA, and warnings about dispensing limits. It also notes storage at 20° to 25°C and keeping out of reach of children.*
FDA Label Image

Package Label-principal Display Panel (200 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)

Package Label-principal Display Panel (200 mg Blister Carton 100 (10 x 10) Unit-dose Tablets)
Packaging label for Clozapine Tablets USP 200 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates a unit-dose package containing 100 tablets (10 x 10) and includes storage instructions, dosing advisory, and safety warnings. The design features the product name and strength prominently, with NDC 65862-847-78 visible on the label.*
FDA Label Image

Chemical Structure (Clozapine Str)

Chemical Structure (Clozapine Str)
Chemical structure diagram of clozapine showing its molecular formula C18H19ClN4 and molecular weight 326.83, depicting the arrangement of its rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.